---
$id: https://graph.org.ai/products/commodity/51142037
$type: Product
source: UNSPSC
code: "51142037"
title: "Bucetin"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bucetin

**UNSPSC Code**: 51142037
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an analgesic agent with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6M7CVQ8PF8, chemically known as p-butyrophenetidide, 3-hydroxy- but generally known as bucetin, which bears US NIH Compound Identifier 14130. European Medicines Agency schedules Bucetin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05942MIG. The term BUCETIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules bucetin in its Anatomical Therapeutic Chemical (ATC) Classification. BUCETIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bucetin under HS 29242995 and SITC 51479. As of Q4 2014, BUCETIN remains the US FDA Preferred Term for this commodity. Bucetin bears US NLM identifiers UMLS ID C0054195 and NCI Concept Code C72112. SMILES: CCOC1=CC=C(C=C1)NC(=O)CC(C)O.

